Evaluates a fiber balloon catheter for improved light delivery in bile duct tumors, suggesting enhanced therapy effectiveness.
BACKGROUND: Intraductal photodynamic therapy (PDT) is a promising minimally invasive treatment for bile duct tumors, but clinical efficacy is limited by uneven intraductal light distribution and light dose attenuation induced by intraluminal blood and bile. OBJECTIVE: To develop an optical transmission device for intraductal PDT of bile duct tumors and optimize the light irradiation strategy. METHODS: The power density distribution was analyzed by COMSOL simulation, and laser attenuation by blood and bile was quantified using an integrating sphere power meter. A fiber-balloon catheter was constructed and evaluated in two pigs that received hematoporphyrin derivative (2 mg/kg) 48 hours preoperatively. Under cholangiographic guidance, the device was inserted via enterotomy, and laser irradiation was delivered at 100 mW/cm² for 1200 s. Histopathology was assessed at 3 days post-PDT. RESULTS: Blood and bile caused 32.5% to 45.8% laser power attenuation. In a 1-cm-diameter duct, eccentric fiber positioning produced 2- to 3-fold wall power density variations. The balloon catheter maintained stable central fiber positioning, expelled intraluminal fluids, and caused no adverse events. Histopathology revealed circumferential, uniform bile duct epithelial necrosis at 3 days post-PDT. CONCLUSIONS: The cylindrical fiber balloon catheter is safe and feasible, and it can effectively improve the uniformity of light irradiation during intraductal PDT for bile duct tumors.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: